How is oncology adapting to COVID-19?
Disruptions in cancer care in the era of COVID-19
‘Like a coin flip’: Assay denies some cancer patients new drug
Investigators find fault with an assay used to determine which triple-negative breast cancer patients are eligible to receive atezolizumab.
Mammography does not reduce breast cancer deaths in women 75 and older
An observational study showed modest benefit for annual mammography in women aged 70-74 years, while women aged 75 years and older saw no benefit...
Glaring gap in CV event reporting in pivotal cancer trials
Breast cancer treatments veer from guidelines
Clinicians used genetic test results correctly when making surgical decisions, but decisions about radiotherapy and chemotherapy did not align...
Data emerging to support personalized nutrition in oncology
SAN DIEGO – Fasting has been linked to improvements in chemotherapy efficacy and decreased side effects.
Pembrolizumab plus chemo boosts pCR rate in TNBC
SAN ANTONIO – The immune checkpoint inhibitor added to standard chemotherapy increased the likelihood of a pathologic complete remission,...
Ten-year results support partial breast irradiation
SAN ANTONIO – There was no statistically significant difference in 10-year ipsilateral breast tumor recurrence between those who received...
Though metastatic breast cancer survival is improving, rates vary by region
A lag in survival improvement across different regions suggests that some groups and regions may benefit unequally from treatment advances as well...